• Associations between trait anxiety, insulin resistance, and atherosclerosis in the elderly: a pilot cross-sectional study.
  (Narita K, et.al. Psychoneuroendocrinology. 2008 Apr;33(3):305-12.)
  View Abstract

• Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
  (Custodis F, et.al. Circulation. 2008 May 6;117(18):2377-87. Epub 2008 Apr 28.)
  View Abstract
• N-nitrosodiethylamine-induced toxicity in relation to oxidative stress and development of atherosclerosis in hypercholesterolemic diet-fed rabbits.
  (Mittal G, et.al. Exp Toxicol Pathol. 2008 Apr;59(6):409-14. Epub 2008 Jan 25.)
  View Abstract
• Antioxidant gene therapy for cardiovascular disease: current status and future perspectives.
  (Levonen AL, et.al. Circulation. 2008 Apr 22;117(16):2142-50. Review.)
  View Abstract
• Gene-environment interaction and oxidative stress in cardiovascular disease.
  (Stephens JW, et.al. Atherosclerosis. 2008 Apr 12. [Epub ahead of print])
  View Abstract

• Increased lipoprotein(a) in metabolic syndrome: is it a contributing factor to premature atherosclerosis?
  (Bozbas, et.al. Anadolu Kardiyol Derg. 2008 Apr;8(2):111-5.)
  View Abstract

BIOMARKERS

• Immune regulator cells: circulating biomarker factories in cardiovascular disease.
  (Pasterkamp G, et.al. Clin Sci (Lond). 2008 Apr 3. [Epub ahead of print])
  View Abstract

• Prevention and noninvasive management of coronary atherosclerosis in patients with diabetes.
  (Bourassa MG, et.al. Curr Atheroscler Rep. 2008 Apr;10(2):106-16.)
  View Abstract
• Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.
  (Howard BV, et.al. JAMA. 2008 Apr 9;299(14):1678-89.)
  View Abstract
• Respiratory infection recurrence and passive smoking in early atherosclerosis in children and adolescents with type 1 diabetes.
  (Odermarsky M, et.al. Eur J Clin Invest. 2008 Jun;38(6):381-8. Epub 2008 Apr 24.)
  View Abstract
• Quantitative trait analysis of type 2 diabetes susceptibility loci identified from whole genome association studies in the Insulin Resistance Atherosclerosis Family Study.
  (Palmer ND, et.al. Diabetes. 2008 Apr;57(4):1093-100. Epub 2008 Feb 5.)
  View Abstract
• Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study.
  (Yeh HC, et.al. Diabetes Care. 2008 Apr;31(4):741-6. Epub 2007 Dec 4.)
  View Abstract
• Insulin resistance as a risk factor for carotid atherosclerosis: a comparison of the Homeostasis Model Assessment and the short insulin tolerance test.
  (Sourij H, et.al. Stroke. 2008 Apr;39(4):1349-51. Epub 2008 Feb 28.)
  View Abstract

• Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure.
  (Ivanovski O, et.al. J Urol. 2008 Apr;179(4):1631-6. Epub 2008 Mar 4.)
  View Abstract
• Early changes in arterial structure and function following statin initiation: quantification by magnetic resonance imaging.
  (Lee JM, et.al. Atherosclerosis. 2008 Apr;197(2):951-8. Epub 2007 Oct 30.)
  View Abstract
• Paclitaxel associated with cholesterol-rich nanoemulsions promotes atherosclerosis regression in the rabbit.
  (Maranhão RC, et.al. Atherosclerosis. 2008 Apr;197(2):959-66. Epub 2008 Mar 4.)
  View Abstract
• Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.
  (Nissen SE, et.al. JAMA. 2008 Apr 2;299(13):1561-73. Epub 2008 Mar 31.)
  View Abstract
• Ultrasonic gene and drug delivery to the cardiovascular system.
  (Mayer CR, et.al. Adv Drug Deliv Rev. 2008 Apr 3. [Epub ahead of print])
  View Abstract
• Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial.
  (Nissen SE, et.al. JAMA. 2008 Apr 2;299(13):1547-60. Epub 2008 Apr 1.)
  View Abstract
• Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure.
  (Segreti JA, et.al. J Pharmacol Exp Ther. 2008 Apr;325(1):331-40. Epub 2008 Jan 2.)
  View Abstract
• Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease. A Prospective, Multicenter, Observational Study.
  (Toyoda K, et.al. Stroke. 2008 Apr 3. [Epub ahead of print])
  View Abstract
• Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10).
  (Wilcox R, et.al. Am Heart J. 2008 Apr;155(4):712-7. Epub 2008 Feb 21.)
  View Abstract

• Visual scoring of atherosclerosis in chest computed tomography: findings among male construction workers.
  (Hiltunen A, et.al. Acta Radiol. 2008 Apr;49(3):328-36.)
  View Abstract
• Differences in kidney function and incident hypertension: the multi-ethnic study of atherosclerosis.
  (Kestenbaum B, et.al. Ann Intern Med. 2008 Apr 1;148(7):501-8.)
  View Abstract
• Australians at risk: management of cardiovascular risk factors in the REACH Registry.
  (Reid C, et.al. Heart Lung Circ. 2008 Apr;17(2):114-8. Epub 2007 Oct 10.)
  View Abstract
• Prevalence in digital panoramic radiographs of carotid area calcification among Iraqi individuals with stroke-related disease.
  (Uthman AT, et.al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Apr;105(4):e68-73.)
  View Abstract
• High-density lipoprotein cholesterol and objective measures of lower extremity performance in older nondisabled persons: the InChianti study.
  (Volpato S, et.al. J Am Geriatr Soc. 2008 Apr;56(4):621-9. Epub 2008 Jan 16.)
  View Abstract
• Heritability of carotid intima-media thickness: a twin study.
  (Zhao J, et.al. Atherosclerosis. 2008 Apr;197(2):814-20. Epub 2007 Sep 6.)
  View Abstract 

• C242T polymorphism of NADPH oxidase p22phox and recurrence of cardiovascular events in coronary artery disease.
  (Arca M, et.al. Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):752-7. Epub 2008 Jan 31.)
  View Abstract
• Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.
  (Szeto CC, et.al. Am J Nephrol. 2008 Apr 17;28(5):715-722. [Epub ahead of print])
  View Abstract
• Investigating the association between K198N coding polymorphism in EDN1 and hypertension, lipoprotein levels, the metabolic syndrome and cardiovascular disease.
  (Wiltshire S, et.al. Hum Genet. 2008 Apr;123(3):307-13. Epub 2008 Feb 21.)
  View Abstract
• Common variants in the CRP gene in relation to longevity and cause-specific mortality in older adults: the Cardiovascular Health Study.
  (Hindorff LA, et.al. Atherosclerosis. 2008 Apr;197(2):922-30. Epub 2007 Sep 21.)
  View Abstract
• Cardiovascular disease risk prediction using genetic information (gene scores): is it really informative?
  (Humphries SE, et.al. Curr Opin Lipidol. 2008 Apr;19(2):128-32. Review.)
  View Abstract
• SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease.
  (Malerba G, et.al. Lipids. 2008 Apr;43(4):289-99. Epub 2008 Mar 5.)
  View Abstract

• Noninvasive detection and localization of vulnerable plaque and arterial thrombosis with computed tomography angiography/positron emission tomography.
  (Aziz K, et.al. Circulation. 2008 Apr 22;117(16):2061-70. Epub 2008 Apr 7.)
  View Abstract
• Asymmetric development of peripheral atherosclerosis in patients with erectile dysfunction: an ultrasonographic study.
  (Foresta C, et.al. Atherosclerosis. 2008 Apr;197(2):889-95. Epub 2007 Sep 14.)
  View Abstract
• Comparison between gadolinium and iodine contrast for percutaneous intervention in atherosclerotic renal artery stenosis: clinical outcomes.
  (Kane GC, et.al. Nephrol Dial Transplant. 2008 Apr;23(4):1233-40. Epub 2008 Feb 5.)
  View Abstract
• Technology insight: in vivo coronary plaque classification by intravascular ultrasonography radiofrequency analysis.
  (König A, et.al. Nat Clin Pract Cardiovasc Med. 2008 Apr;5(4):219-29. Epub 2008 Feb 26. Review.)
  View Abstract
• Semiautomated quantification of the mass and distribution of vascular calcification with multidetector CT: method and evaluation.
  (Raman R, et.al. Radiology. 2008 Apr;247(1):241-50. Epub 2008 Feb 21.)
  View Abstract

• Immune regulator cells: circulating biomarker factories in cardiovascular disease.
  (Pasterkamp G, et.al. Clin Sci (Lond). 2008 Apr 3. [Epub ahead of print])
  View Abstract
• Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk.
  (Tebas P, et.al. PLoS ONE. 2008 Apr 23;3(4):e2021.)
  View Abstract

• A rabbit model of atherosclerosis at carotid artery: MRI visualization and histopathological characterization.
  (Ma ZL, et.al. Eur Radiol. 2008 Apr 17. [Epub ahead of print])
  View Abstract

• Nonalcoholic fatty liver disease and carotid atherosclerosis in children.
  (Pacifico L, et.al. Pediatr Res. 2008 Apr;63(4):423-7.)
  View Abstract

• Menopausal complaints are associated with cardiovascular risk factors.
  (Gast GC, et.al. Hypertension. 2008 Apr 7. [Epub ahead of print])
  View Abstract

• Increased lipoprotein(a) in metabolic syndrome: is it a contributing factor to premature atherosclerosis?
  (Bozbas, et.al. Anadolu Kardiyol Derg. 2008 Apr;8(2):111-5.)
  View Abstract
• Childhood obesity, hypertension, the metabolic syndrome and adult cardiovascular disease.
  (Beilin L, et.al. Clin Exp Pharmacol Physiol. 2008 Apr;35(4):409-11.)
  View Abstract
• Magnesium in hypertension, cardiovascular disease, metabolic syndrome, and other conditions: a review.
  (Champagne CM.Nutr Clin Pract. 2008 Apr-May;23(2):142-51.)
  View Abstract
• Renal function and metabolic syndrome components on cardiovascular and all-cause mortality.
  (Chien KL, et.al. Atherosclerosis. 2008 Apr;197(2):860-7. Epub 2007 Sep 12.)
  View Abstract
• Metabolic syndrome and Framingham risk score for prediction of cardiovascular events in Caribbean Indian patients with blood glucose abnormalities.
  (Jaquet A, et.al. Diabetes Metab. 2008 Apr;34(2):177-81. Epub 2008 Mar 18.)
  View Abstract
• Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease.
  (Patel SB, et.al. Curr Hypertens Rep. 2008 Apr;10(2):131-7.)
  View Abstract
• Metabolic syndrome risks of cardiovascular disease: differences between HIV-positive and HIV-negative?
  (Reeds DN.J Cardiometab Syndr. 2008 Spring;3(2):79-82.)
  View Abstract
• Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease.
  (Stehouwer CD, et.al. Diabetologia. 2008 Apr;51(4):527-39. Epub 2008 Feb 1.)
  View Abstract
• Relationship between metabolic syndrome and sleep-disordered breathing in patients with cardiovascular disease--metabolic syndrome as a strong factor of nocturnal desaturation.
  (Takama N, et.al. Intern Med. 2008;47(8):709-15. Epub 2008 Apr 16.)
  View Abstract

• Perforation of the ascending aorta with a hematoma extending into the left-side upper extrapleural cavity.
  (Kadohama T, et.al. Interact Cardiovasc Thorac Surg. 2008 Apr;7(2):318-9. Epub 2007 Dec 18.)
  View Abstract
• Acute intraoperative aortic dissection following axillary artery cannulation.
  (Rokkas CK, et.al. Interact Cardiovasc Thorac Surg. 2008 Apr;7(2):288-9. Epub 2008 Jan 15.)
  View Abstract

• Diet and cardiovascular risk in university marching band, dance team and cheer squad members: a cross-sectional study.
  (Sharma SV, et.al. J Int Soc Sports Nutr. 2008 Apr 18;5:9.)
  View Abstract
• Low protein diet fed exclusively during mouse oocyte maturation leads to behavioural and cardiovascular abnormalities in offspring.
  (Watkins AJ, et.al. J Physiol. 2008 Apr 15;586(8):2231-44. Epub 2008 Feb 28.)
  View Abstract
• Phenolics from purple grape, apple, purple grape juice and apple juice prevent early atherosclerosis induced by an atherogenic diet in hamsters.
  (Décordé K, et.al. Mol Nutr Food Res. 2008 Apr;52(4):400-7.)
  View Abstract
• Associations of the local food environment with diet quality--a comparison of assessments based on surveys and geographic information systems: the multi-ethnic study of atherosclerosis.
  (Moore LV, et.al. Am J Epidemiol. 2008 Apr 15;167(8):917-24. Epub 2008 Feb 27.)
  View Abstract

• Childhood obesity, hypertension, the metabolic syndrome and adult cardiovascular disease.
  (Beilin L, et.al. Clin Exp Pharmacol Physiol. 2008 Apr;35(4):409-11.)
  View Abstract
• Obesity indices in relation to cardiovascular disease risk factors among young adult female students.
  (Farajian P, et.al. Br J Nutr. 2008 Apr;99(4):918-24. Epub 2007 Oct 5.)
  View Abstract
• Cardiovascular and metabolic effects of obesity.
  (Morris MJ.Clin Exp Pharmacol Physiol. 2008 Apr;35(4):416-9.)
  View Abstract
• Leptin: linking obesity, the metabolic syndrome, and cardiovascular disease.
  (Patel SB, et.al. Curr Hypertens Rep. 2008 Apr;10(2):131-7.)
  View Abstract
• Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women.
  (Zhang C, et.al. Circulation. 2008 Apr 1;117(13):1658-67. Epub 2008 Mar 24.)
  View Abstract

• High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study.
  (Margeirsdottir HD, et.al. Diabetologia. 2008 Apr;51(4):554-561. Epub 2008 Jan 15.)
  View Abstract
• Respiratory infection recurrence and passive smoking in early atherosclerosis in children and adolescents with type 1 diabetes.
  (Odermarsky M, et.al. Eur J Clin Invest. 2008 Jun;38(6):381-8. Epub 2008 Apr 24.)
  View Abstract
• Nonalcoholic fatty liver disease and carotid atherosclerosis in children.
  (Pacifico L, et.al. Pediatr Res. 2008 Apr;63(4):423-7.)
  View Abstract

• Incident physical disability in people with lower extremity peripheral arterial disease: The role of cardiovascular disease.
  (Brach JS, et.al. J Am Geriatr Soc. 2008 Apr 1. [Epub ahead of print])
  View Abstract
• Knowledge and awareness of peripheral vascular disease are poor among women at risk for cardiovascular disease.
  (Bush RL, et.al. J Surg Res. 2008 Apr;145(2):313-9. Epub 2008 Jan 28.)
  View Abstract
• Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.
  (González-Clemente JM, et.al. Diabet Med. 2008 Apr;25(4):427-34. Epub 2008 Mar 13.)
  View Abstract
• Asymmetric development of peripheral atherosclerosis in patients with erectile dysfunction: an ultrasonographic study.
  (Foresta C, et.al. Atherosclerosis. 2008 Apr;197(2):889-95. Epub 2007 Sep 14.)
  View Abstract

• Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis.
  (Dong B, et.al. Arterioscler Thromb Vasc Biol. 2008 Apr 10. [Epub ahead of print])
  View Abstract
• Associations of insulin-like growth factor (IGF)-I, IGF-II, IGF binding protein (IGFBP)-2 and IGFBP-3 with ultrasound measures of atherosclerosis and plaque stability in an older adult population.
  (Martin RM, et.al. J Clin Endocrinol Metab. 2008 Apr;93(4):1331-8. Epub 2008 Jan 22.)
  View Abstract
• Rate of atherosclerotic plaque formation predicts cardiovascular events in ESRD.
  (Benedetto FA, et.al. J Am Soc Nephrol. 2008 Apr;19(4):757-63. Epub 2008 Jan 9.)
  View Abstract

• Impact of subclinical carotid atherosclerosis on incident chronic kidney disease in the elderly.
  (Chonchol M, et.al. Nephrol Dial Transplant. 2008 Apr 3. [Epub ahead of print])
  View Abstract
• Differences in kidney function and incident hypertension: the multi-ethnic study of atherosclerosis.
  (Kestenbaum B, et.al. Ann Intern Med. 2008 Apr 1;148(7):501-8.)
  View Abstract
• N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease: the African American Study of Kidney Disease and Hypertension (AASK).
  (Astor BC, et.al. Circulation. 2008 Apr 1;117(13):1685-92. Epub 2008 Mar 24.)
  View Abstract
• Achievement of therapeutic goals and utilization of evidence-based cardiovascular therapies in coronary heart disease patients with chronic kidney disease.
  (Lahoz C, et.al. Am J Cardiol. 2008 Apr 15;101(8):1098-102. Epub 2008 Feb 7.)
  View Abstract
• CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
  (McCullough PA, et.al. Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S38-45.)
  View Abstract
• Ambulatory blood pressure and cardiovascular risk in chronic kidney disease.
  (Palatini P.Curr Hypertens Rep. 2008 Apr;10(2):119-26.)
  View Abstract
• Inflammation and cardiovascular events in individuals with and without chronic kidney disease.
  (Weiner DE, et.al. Kidney Int. 2008 Apr 9. [Epub ahead of print])
  View Abstract

• Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.
  (González-Clemente JM, et.al. Diabet Med. 2008 Apr;25(4):427-34. Epub 2008 Mar 13.)
  View Abstract
• The mechanism of phosphorus as a cardiovascular risk factor in CKD.
  (Mathew S, et.al. J Am Soc Nephrol. 2008 Apr 16. [Epub ahead of print])
  View Abstract
• Metabolic syndrome: a major risk factor for atherosclerosis in HIV-infected patients (SHIVA study).
  (Martin Lde S, et.al. Presse Med. 2008 Apr;37(4 Pt 1):579-84. Epub 2008 Feb 29.)
  View Abstract
• Acrolein induces inflammatory response underlying endothelial dysfunction: a risk factor for atherosclerosis.
  (Park YS, et.al. Ann N Y Acad Sci. 2008 Apr;1126:185-9.)
  View Abstract
• Insulin resistance as a risk factor for carotid atherosclerosis: a comparison of the Homeostasis Model Assessment and the short insulin tolerance test.
  (Sourij H, et.al. Stroke. 2008 Apr;39(4):1349-51. Epub 2008 Feb 28.)
  View Abstract

• Insulin resistance as a risk factor for carotid atherosclerosis: a comparison of the Homeostasis Model Assessment and the short insulin tolerance test.
  (Sourij H, et.al. Stroke. 2008 Apr;39(4):1349-51. Epub 2008 Feb 28.)
  View Abstract
• The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment.
  (Andrikoula M, et.al. Diabetes Obes Metab. 2008 Apr;10(4):271-8.)
  View Abstract
• Cardiovascular risk assessment through target organ damage: role of carotid to femoral pulse wave velocity.
  (Boutouyrie P, et.al. Clin Exp Pharmacol Physiol. 2008 Apr;35(4):530-3.)
  View Abstract
• Assessment of cardiovascular risk in shift healthcare workers.
  (Copertaro A, et.al. Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):224-9.)
  View Abstract
• Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice.
  (Wells S, et.al. Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):173-8.)
  View Abstract

• Age-related macular degeneration and mortality from cardiovascular disease or stroke.
  (Tan JS, et.al. Br J Ophthalmol. 2008 Apr;92(4):509-12. Epub 2008 Feb 29.)
  View Abstract
• Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke.
  (Mazighi M, et.al. Stroke. 2008 Apr;39(4):1142-7. Epub 2008 Feb 28.)
  View Abstract

• Cardio-ankle vascular index is a candidate predictor of coronary atherosclerosis.
  (Nakamura K, et.al. Circ J. 2008 Apr;72(4):598-604.)
  View Abstract
• Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease.
  (Berends AL, et.al. Hypertension. 2008 Apr;51(4):1034-41. Epub 2008 Feb 7.)
  View Abstract
• Vascular system: role of nitric oxide in cardiovascular diseases.
  (Bian K, et.al. J Clin Hypertens (Greenwich). 2008 Apr;10(4):304-10.)
  View Abstract
• Cardiovascular prognostic value of vascular involvement in Behcet's disease.
  (Caliskan M, et.al. Int J Cardiol. 2008 Apr 25;125(3):428-30. Epub 2007 Apr 3.)
  View Abstract
• Anemia as an independent predictor of perioperative and long-term cardiovascular outcome in patients scheduled for elective vascular surgery.
  (Dunkelgrun M, et.al. Am J Cardiol. 2008 Apr 15;101(8):1196-200. Epub 2008 Feb 7.)
  View Abstract
• Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis.
  (Siegel-Axel D, et.al. Cardiovasc Res. 2008 Apr 1;78(1):8-17. Epub 2008 Jan 24.)
  View Abstract
• Role of chlamydia pneumoniae in atherosclerosis.
  (Watson C, et.al. Clin Sci (Lond). 2008 Apr;114(8):509-31. Review.)
  View Abstract
• Relationship between coronary remodeling and plaque characterization in patients without clinical evidence of coronary artery disease.
  (Kume T, et.al. Atherosclerosis. 2008 Apr;197(2):799-805. Epub 2007 Sep 5.)
  View Abstract
• Atheroprotective role of interleukin-6 in diet- and/or pathogen-associated atherosclerosis using an ApoE heterozygote murine model.
  (Madan M, et.al. Atherosclerosis. 2008 Apr;197(2):504-14. Epub 2007 Apr 6.)
  View Abstract

• The circulating inactive form of matrix Gla protein (ucMGP) as a biomarker for cardiovascular calcification.
  (Cranenburg EC, et.al. J Vasc Res. 2008 Apr 10;45(5):427-436. [Epub ahead of print])
  View Abstract
• Relationships of thoracic aortic wall calcification to cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA).
  (Takasu J, et.al. Am Heart J. 2008 Apr;155(4):765-71. Epub 2008 Feb 21.)
  View Abstract
• A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls.
  (Khurma V, et.al. Arthritis Rheum. 2008 Apr 15;59(4):591-7.)
  View Abstract
• Aneurysmal wall calcification predicts natural history of small abdominal aortic aneurysms.
  (Lindholt JS.Atherosclerosis. 2008 Apr;197(2):673-8. Epub 2007 Apr 17.)
  View Abstract

RECOMMENDED READING

The following articles were recommended by: Eder Quintão, MD

• Egg consumption in relation to cardiovascular disease and mortality: the Physicians' Health Study.
  (Djoussé L, et al. Am J Clin Nutr. 2008 Apr;87(4):964-9.)
  View Abstract
• Vascular effects of diet supplementation with plant sterols.
  (Weingärtner O, et al. J Am Coll Cardiol. 2008 Apr 22;51(16):1553-61)
  View Abstract
• Vascular effects of diets, especially plant sterol ester consumption.
  (Miettinen TA, et al. J Am Coll Cardiol. Apr 22;51(16):1562-1563 (2008)
  View Abstract
• Inverse relation between dietary intake of naturally occurring plant sterols and serum cholesterol in northern Sweden.
  (Klingberg S, et al. Am J Clin Nutr. 87(4):993-1001 (2008)
  View Abstract
• Cholesterol Absorption From the Intestine Is a Major Determinant of Reverse Cholesterol Transport From Peripheral Tissue Macrophages.
  (Sehayek E, et al. Arterioscler Thromb Vasc Biol. Apr 17. 2008)
  View Abstract
• Acute Elevation of Plasma PLTP Activity Strongly Increases Pre-existing Atherosclerosis.
  (Moerland M, et al. Arterioscler Thromb Vasc Biol. Apr 17 2008 [Epub ahead of print])
  View Abstract
• Association of Stearoyl-CoA Desaturase 1 Activity With Familial Combined Hyperlipidemia.
  (Mar-Heyming R, et al. Arterioscler Thromb Vasc Biol. Mar 13 2008 [Epub ahead of print])
  View Abstract
• Cholesterol Synthesis Inhibition Elicits an Integrated Molecular Response in Human Livers Including Decreased ACAT2.
  (Parini P,et al. Arterioscler Thromb Vasc Biol. Mar 13 2008 [Epub ahead of print])
  View Abstract
• Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
  (Shepherd J, et al. J Am Coll Cardiol. Apr 15;51(15):1448-1454 (2008)
  View Abstract
• Presecretory oxidation, aggregation, and autophagic destruction of apoprotein-B: a pathway for late-stage quality control.
  (Pan M, et al. Proc Natl Acad Sci U S A. Apr 15;105(15):5862-5867. 2008)
  View Abstract
• Cross-talk Between Statins and PPARalpha in Cardiovascular Diseases: Clinical Evidence and Basic Mechanisms.
  (Paumelle R, et al. Trends Cardiovasc Med. Apr;18(3):73-78 (2008)
  View Abstract
• Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.
  (Howard BV, et al. JAMA. Apr 9;299(14):1678-1689 (2008). Comment in: JAMA. Apr 9;299(14):1718-1720 (2008)
  View Abstract
• Human CETP expression enhances the mouse survival rate in an experimental systemic inflammation model: a novel role for CETP.
  (Cazita PM, et al. Shock. 2008 Apr 3. [Epub ahead of print])
  View Abstract